ESGO Prevention Webinars

ESGO Prevention 2

Established in 2019 to fulfil the ESGO vision: Best treatment and prevention in gynaecological cancer, the ESGO Prevention Committee connects more than 70 experts in vaccination, screening, colposcopy, and treatment of pre-invasive disease.

Apart from Prevention webinars, the Prevention Committee produces consensus statements on prevention-related topics. Visit the ESGO Prevention Committee website to learn more about the research we do.

Prof. Murat Gultekin chairs the Committee.

Webinars

ESGO_WEBINARS_PREVENTION_7_04_2026_BANNER_1280x720

Opportunistic salpingectomy for the prevention of ovarian cancer

April 7, 2026 7-8:30 PM CET

  • On the paradigm shift of ovarian cancer genesis - Jurgen Piek
  • Prophylactic salpingectomy - Claudia Marchetti
  • Opportunistic salpingectomy during surgical procedures - Karl Tamussino
  • Patient perspective - Kata Koblos

Moderators: Murat Gultekin

REGISTER HERE

Webinar abstract:

For decades, we believed ovarian cancer began in the ovary. Now, science tells a different story.
This dynamic webinar explores the paradigm shift, identifying the fallopian tube as the true origin of most high-grade serous carcinomas (HGSC). We will review the compelling biological and pathological evidence behind this shift and examine how this discovery is revolutionizing prevention strategies worldwide.
From opportunistic salpingectomy in routine gynecologic surgery to research in mutation carriers at increased risk for HGSC, we will discuss how prophylactic salpingectomy is reshaping cancer prevention. Is salpingectomy with delayed oophorectomy the future for high-risk women? What do ongoing trials reveal?
We will also explore innovative frontiers: can salpingectomy be safely integrated during non-gynecologic procedures? What are the surgical, ethical, and practical challenges?
Finally, we center the patient perspective. With ovarian cancer remaining the fifth leading cause of cancer death among women worldwide, prevention decisions carry emotional and life-altering weight. How can clinicians support informed choices? What is the role of advocacy groups such as ENGAGe in shaping awareness and shared decision-making?
Join us as we redefine the origin of ovarian cancer and rethink prevention.

IPVS March 2026 - Facebook v2
REGISTER HERE

Anal Precancerous lesions in women: epidemiology, screening and prevention

March 25, 2026, 4:30 PM CET

  • Identify high-risk groups of women for anal cancer based on epidemiology, HPV exposure, and other risk factors, and review current guidelines for targeted screening - Ann Burchell
  • Discuss the new ESGO guidelines on anal cancer screening in women - Vesna Kesic
  • Describe comprehensive prevention strategies beyond screening, including patient education, HPV vaccination, and lifestyle modifications such as smoking cessation - Gary Clifford

Moderators: Andreia Albuquerque

Panelist: Sara Vodopivec

Webinar abstract:

Participate in this free webinar to gain key insights into Anal Precancerous Lesions in Women: Epidemiology, Screening and Prevention, presented by IPVS and ESGO Prevention. This session will highlight high-risk groups of women, review the new ESGO anal cancer screening guidelines, and explore comprehensive prevention strategies beyond screening, including HPV vaccination, patient education, and lifestyle modification.

Webinar recordings

IPVS December - Facebook
Webinar recording available on ESGO eAcademy for free upon registration

Colposcopy uncovered: Colposcopy Uncovered: Past, Present, and Future in Cervical Cancer Prevention and Innovation

December 10, 2025, 4 PM CET

  • Colposcopy. History, basic principles, setting, tools, technique - Vesna Kesic
  • The Role of ECC During Colposcopy - Mario Preti
  • Artificial Intelligence in Colposcopy. The PAVE project, phase 2 - Didem Egemen

Moderators: Murat Gultekin, Kimon Chatzistamatou

Panelist: Sara Vodopivec

Webinar abstract:

Explore the evolution of colposcopy, a cornerstone in cervical cancer prevention. Learn about its historical development, the key principles behind the procedure, and its vital role in today’s cervical cancer screening programs. Our experts dive into the ongoing advancements in colposcopy, including the integration of cutting-edge technologies like AI, and how these innovations are shaping its future.

ESGO_prevention_webinar_Oncogenetics_in_Focus_1280X720
Webinar recording available on ESGO eAcademy for free upon registration

Oncogenetics in Focus: From Risk to Prevention in Women’s Cancers

November 11, 2025 7-8:30 PM CET

  • Lynch syndrome: endometrial and ovarian cancer risk - Claudia Marchetti
  • Which genetic tests and variants should be used for screening? - Angela George
  • Genetic and epigenetic variation in cervical preinvasive and invasive disease: Real-world implications - Sarah Bowden

Moderators: Mihaela Grigore, Murat Gultekin

Webinar abstract:

This webinar explored the evolving landscape of oncogenetics with a focus on genetic testing and its role in cancer risk assessment, prevention, and personalized care in gynecologic oncology. Experts discussed the latest advances in genetic screening, including the clinical application of BRCA and Lynch syndrome testing, as well as the emergence of new preventive testing kits now available on the market.

ESGO_prevention_webinar_Beyond_Survival_1280x720
Webinar recording available on ESGO eAcademy for free upon registration

Beyond survival: Psycho-oncology, resilience, quality of life and sexuality after cancer

September 10, 2025 7-8:30 PM CET

  • Preserving quality of life in cancer patients - Houssein El Hajj
  • Can we prevent the long-term effects of treatment? - Elizabeth C. Branco
  • The role of resilience in the coping of patients and HCPs - Elisabeth Andritsch
  • From scars to connection, reclaiming sexual identity after cancer - Icó Tóth

Moderators: Annette Hasenburg, Murat Gultekin

Webinar abstract:

This webinar will focus on key aspects of psycho-oncology relevant to clinical practice, exploring how healthcare professionals can support and enhance the quality of life of cancer patients throughout the disease trajectory. Discussions will address whether long-term psychological and physical effects of treatment can be anticipated or prevented, and how early supportive interventions may impact survivorship.

ESGO_prevention_webinar_HPV_360_1280x720
Webinar recording available on ESGO eAcademy for free upon registration

HPV 360° - Innovations in Vaccination and Screening

July 9, 2025 7-8:30 PM CET

  • New trends in vaccination: single dose - Elmar Joura
  • New HPV vaccines on the market - Utku Akgor
  • New trends in screening - Alex Vorsters
  • High-risk HPV assays validated for screening - Marc Arbyn

Moderators: Rita Sousa, Murat Gultekin

Webinar abstract:

The session highlights newly available HPV vaccines and their potential impact, as well as the growing body of evidence supporting simplified vaccination schedules, including single-dose strategies. Speakers examine current trends in screening, such as risk-based approaches and the application of high-risk HPV assays that have been validated for primary screening. Special attention will be given to the validation principles required for HPV tests, and to assays that target a limited number of HPV types, exploring their potential role in future screening programs. This webinar offers a comprehensive overview for clinicians, researchers, and public health professionals interested in the evolving landscape of HPV prevention and control.

RECORDING: Virtual conference on cervical cancer elimination in Africa June 11, 2025

Session 1: Update on Cervical Cancer Prevention and Current Situation in Africa

Moderator: Jalid Sehouli

  • Murat Gultekin (Turkey),
  • Andreas Ullrich (Germany),
  • Mohamed Afifi (WHO EMRO),
  • David Atallah (MEMAGO),
  • Jalid Sehouli (PARSGO),
  • Hesham El Ghazaly (BGICS),
  • Dilyara Kaidarova (Cent-East),
  • Marc Arbyn (Belgium)
Watch the 1st Session!
Cervical cancer conference

Session 2: New Trends in HPV Vaccines Focused on Africa

Moderator: Elmar Joura

  • Elmar Joura (Austria)
  • Laia Bruni (Spain)
  • Nelly Mugo (Kenya)
  • Anna Giuliano (USA)
  • Bhagyalaxmi Nayak (India)
Watch the 2nd Session!

Session 3: New trends in screening focused on Africa

Moderator: Murat Gultekin

  • Mario Poljak (Slovenia),
  • Nadja Taumberger (Austria),
  • Yalin Kilic (Turkey),
  • Basel Refky (Egypt),
  • Reda Hemida (Egypt),
  • Andreas Kaufmann (Germany),
  • Gabriel Reina (Spain),
  • Nina Dhollander (Belgium),
  • Mohammed Ezzet Charfi (Senegal),
  • Silvia De Sanjose (Spain),
  • Didem Egemen (USA),
  • Omar Gassama (Senegal)

Session 4: Colposcopy scenarios focused on Africa

Moderator: Mario Preti

  • Mihaela Grigore (Romania)
  • Vesna Kesic (Serbia)
  • Mario Preti (Italy)
  • Patrick Petignat (Switzerland)
  • Andre Boris Kind (Switzerland)
  • Mario Preti (Italy)
  • Didem Egemen (USA)

Session 5: Limited resource treatment focused on Africa

Moderator: Reda Hemida

  • David Cibula (CZ)
  • Maria Kyrgiou (UK)
  • Reda Hemida (Egypt), Rafik Barakat (Egypt)
  • Neamat Hegazy (Egypt)
  • Murat Gultekin (Turkey)
Watch the 3rd Session!
Watch the 4th Session!
Watch the 5th Session!

This is the second edition of a successful full-day virtual event that attracted 1300+ registered participants in 2024. It is focused on vaccination, screening, colposcopy, and treatment of pre-invasive disease in a limited-resource context.

Check out the programme for more details (available in PDF here):

Watch summary thank you video after the conference!